Avapritinib reduces symptoms and mast cell burden in systemic mastocytosis
Abstract Background Mastocytosis is driven by a clonal expansion of mast cells, commonly triggered by the KIT D816V mutation which is present in over 90% of adult patients. Individuals with indolent systemic mastocytosis (ISM) frequently experience recurrent anaphylaxis and mast cell mediator-relate...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-09-01
|
| Serier: | Allergy, Asthma & Clinical Immunology |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s13223-025-00986-z |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|